Compare Stocks

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEAC Flying Eagle Acquisition	$5.84 -6.0%	$21.06	$9.81 ▼ $21.27	$503.70M	N/A	1.78 million shs	205,898 shs
GSAH GS Acquisition Holdings Corp II	$10.54	$10.23	$9.83 ▼ $16.66	$988.13M	-0.11	2.05 million shs	2.63 million shs
IMVT Immunovant	$30.52 +0.2%	$33.54	$14.59 ▼ $45.58	$4.43B	0.65	1.22 million shs	143,795 shs
LPRO Open Lending	$4.86 -1.0%	$6.86	$4.80 ▼ $11.99	$577.76M	0.99	454,557 shs	129,734 shs
VRRM Verra Mobility	$24.18 +0.0%	$23.28	$16.22 ▼ $25.57	$4.01B	1.17	1.07 million shs	70,856 shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEAC Flying Eagle Acquisition	-5.96%	-8.46%	-7.15%	+16.80%	+738.36%
GSAH GS Acquisition Holdings Corp II	0.00%	0.00%	0.00%	0.00%	0.00%
IMVT Immunovant	+3.82%	-0.16%	-0.20%	-27.88%	+113.52%
LPRO Open Lending	-3.54%	-12.01%	-26.39%	-33.20%	-28.84%
VRRM Verra Mobility	-0.98%	-2.42%	+2.50%	+9.91%	+44.90%

Forget Nvidia, buy this A.I. Stock Now (Ad)

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FEAC Flying Eagle Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GSAH GS Acquisition Holdings Corp II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMVT Immunovant	2.4916 of 5 stars	4.5	2.0	0.0	0.0	2.3	1.7	0.0
LPRO Open Lending	4.1741 of 5 stars	4.2	0.0	0.0	0.0	1.4	3.3	3.1
VRRM Verra Mobility	1.1856 of 5 stars	1.3	3.0	0.0	0.0	2.9	0.8	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEAC Flying Eagle Acquisition	N/A	N/A	N/A	N/A
GSAH GS Acquisition Holdings Corp II	N/A	N/A	N/A	N/A
IMVT Immunovant	3.00	Buy	$48.00	57.27% Upside
LPRO Open Lending	2.44	Hold	$7.07	45.50% Upside
VRRM Verra Mobility	2.50	Moderate Buy	$22.33	-7.64% Downside

Current Analyst Ratings

Latest VRRM, IMVT, LPRO, FEAC, and GSAH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/28/2024	IMVT Immunovant	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$50.00
3/26/2024	LPRO Open Lending	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$8.00
3/26/2024	LPRO Open Lending	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$8.00
3/26/2024	LPRO Open Lending	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$7.50 ➝ $7.00
3/25/2024	IMVT Immunovant	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00
3/13/2024	IMVT Immunovant	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$50.00
2/29/2024	LPRO Open Lending	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$5.50 ➝ $7.50
2/28/2024	LPRO Open Lending	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00
2/27/2024	VRRM Verra Mobility	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$19.00 ➝ $20.00
2/20/2024	IMVT Immunovant	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$51.00
2/15/2024	IMVT Immunovant	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$55.00

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEAC Flying Eagle Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
GSAH GS Acquisition Holdings Corp II	$70K	14,116.07	N/A	N/A	$6.96 per share	1.51
IMVT Immunovant	N/A	N/A	N/A	N/A	$2.78 per share	N/A
LPRO Open Lending	$117.46M	4.92	$0.19 per share	25.57	$1.73 per share	2.81
VRRM Verra Mobility	$817.31M	4.91	$1.65 per share	14.65	$2.53 per share	9.56

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEAC Flying Eagle Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GSAH GS Acquisition Holdings Corp II	-$45.26M	N/A	0.00	∞	N/A	-49,263.32%	-9.11%	-5.88%	N/A
IMVT Immunovant	-$210.96M	-$1.84	N/A	N/A	N/A	N/A	-57.97%	-52.47%	5/27/2024 (Estimated)
LPRO Open Lending	$22.07M	$0.17	28.59	12.15	N/A	18.79%	10.45%	5.82%	5/14/2024 (Estimated)
VRRM Verra Mobility	$57.01M	$0.36	67.17	18.89	1.83	6.98%	41.86%	8.93%	5/2/2024 (Estimated)

Latest VRRM, IMVT, LPRO, FEAC, and GSAH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/29/2024	Q4 2023	VRRM Verra Mobility	$0.24	$0.22	-$0.02	$0.42	$201.76 million	$211.01 million
2/27/2024	Q4 2023	LPRO Open Lending	$0.05	-$0.04	-$0.09	-$0.04	$27.55 million	$14.90 million
2/12/2024	12/31/2023	IMVT Immunovant	-$0.43	-$0.36	+$0.07	-$0.36	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEAC Flying Eagle Acquisition	N/A	N/A	N/A	N/A	N/A
GSAH GS Acquisition Holdings Corp II	N/A	N/A	N/A	N/A	N/A
IMVT Immunovant	N/A	N/A	N/A	N/A	N/A
LPRO Open Lending	N/A	N/A	N/A	N/A	N/A
VRRM Verra Mobility	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEAC Flying Eagle Acquisition	N/A	1.02	1.02
GSAH GS Acquisition Holdings Corp II	N/A	0.02	0.02
IMVT Immunovant	N/A	22.14	22.14
LPRO Open Lending	0.68	14.08	14.08
VRRM Verra Mobility	2.44	2.05	1.96

Ownership

Institutional Ownership

Company	Institutional Ownership
FEAC Flying Eagle Acquisition	40.83%
GSAH GS Acquisition Holdings Corp II	49.06%
IMVT Immunovant	47.08%
LPRO Open Lending	78.06%
VRRM Verra Mobility	N/A

Insider Ownership

Company	Insider Ownership
FEAC Flying Eagle Acquisition	N/A
GSAH GS Acquisition Holdings Corp II	N/A
IMVT Immunovant	4.80%
LPRO Open Lending	17.10%
VRRM Verra Mobility	1.02%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
FEAC Flying Eagle Acquisition	N/A	86.25 million	N/A	Not Optionable
GSAH GS Acquisition Holdings Corp II	2	93.75 million	N/A	Not Optionable
IMVT Immunovant	164	145.29 million	138.32 million	Optionable
LPRO Open Lending	210	118.88 million	98.55 million	Optionable
VRRM Verra Mobility	1,788	166.02 million	164.33 million	Optionable

VRRM, IMVT, LPRO, FEAC, and GSAH Headlines

Source	Headline
	Mackenzie Financial Corp Cuts Holdings in Verra Mobility Co. (NASDAQ:VRRM) marketbeat.com - April 16 at 9:27 AM
	Impax Asset Management Group plc Sells 100,000 Shares of Verra Mobility Co. (NASDAQ:VRRM) marketbeat.com - April 11 at 7:59 AM
	ASAZY vs. VRRM: Which Stock Is the Better Value Option? zacks.com - April 10 at 12:40 PM
	Peregrine Capital Management LLC Sells 99,832 Shares of Verra Mobility Co. (NASDAQ:VRRM) marketbeat.com - April 9 at 3:20 PM
	Verra Mobility Joins Connected Vehicle Systems Alliance (COVESA) prnewswire.com - April 9 at 9:15 AM
	When Should You Buy Verra Mobility Corporation (NASDAQ:VRRM)? finance.yahoo.com - April 8 at 10:35 AM
	SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) prnewswire.com - April 1 at 8:45 AM
	Vanguard Group Inc. Has $325.56 Million Holdings in Verra Mobility Co. (NASDAQ:VRRM) marketbeat.com - March 28 at 4:15 AM
	Verra Mobility (NASDAQ:VRRM) Sets New 1-Year High at $26.00 marketbeat.com - March 27 at 10:14 AM
	Verra Mobility (NASDAQ:VRRM) Reaches New 12-Month High at $24.59 marketbeat.com - March 21 at 4:55 PM
	Wall Street's Favorite Russell 2000 Stocks? 3 Names That Could Make You Filthy Rich investorplace.com - March 20 at 6:00 AM
	Verra Mobility (NASDAQ:VRRM) Is Looking To Continue Growing Its Returns On Capital finance.yahoo.com - March 19 at 6:19 PM
	Verra Mobility Co. (NASDAQ:VRRM) Shares Bought by American Century Companies Inc. marketbeat.com - March 19 at 4:43 AM
	Wellington Management Group LLP Purchases 168,418 Shares of Verra Mobility Co. (NASDAQ:VRRM) marketbeat.com - March 17 at 4:47 AM
	Verra Mobility Co. (NASDAQ:VRRM) Director Sells $228,200.00 in Stock insidertrades.com - March 14 at 9:42 AM
	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors to Inquire About Securities Class Action Investigation - VRRM theglobeandmail.com - March 8 at 11:20 PM
	VRRM LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Verra Mobility Corporation Investors to Inquire About Securities Class Action Investigation - VRRM prnewswire.com - March 5 at 4:26 PM
	Chief Legal Officer Jonathan Keyser Sells Shares of Verra Mobility Corp (VRRM) finance.yahoo.com - March 5 at 12:46 AM
	Verra Mobility Corporation (NASDAQ:VRRM) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 4 at 2:07 PM
	Verra Mobility price target raised by $2 at UBS, here's why realmoney.thestreet.com - March 4 at 9:06 AM
	VRRM Dec 2024 20.000 put ca.finance.yahoo.com - March 4 at 12:06 AM
	Verra Mobility Corporation Just Missed Earnings - But Analysts Have Updated Their Models finance.yahoo.com - March 3 at 2:05 PM
	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors to Inquire About Securities Class Action Investigation – VRRM businesswire.com - March 2 at 6:05 PM
	Verra Mobility Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags finance.yahoo.com - March 2 at 2:10 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Flying Eagle Acquisition

NYSE:FEAC

Flying Eagle Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Los Angeles, California.

GS Acquisition Holdings Corp II

NYSE:GSAH

GS Acquisition Holdings Corp II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar transaction with one or more businesses. It focuses on seeking opportunities in diversified industrial, healthcare, technology, media and telecom, and alternatives asset management sectors. The company was incorporated in 2018 and is based in New York, New York.

Immunovant

NASDAQ:IMVT

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Open Lending

NASDAQ:LPRO

Open Lending Corporation provides lending enablement and risk analytics solutions to credit unions, regional banks, finance companies, and captive finance companies of automakers in the United States. The company offers Lenders Protection Program (LPP), which is a cloud-based automotive lending platform that provides loan analytics solutions and automated issuance of credit default insurance with third-party insurance providers. Its LPP products include loan analytics, risk-based loan pricing, risk modeling, and automated decision technology for automotive lenders. Open Lending Corporation was founded in 2000 and is based in Austin, Texas.

Verra Mobility

NASDAQ:VRRM

Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Australia, Canada, and Europe. It operates through three segments: Commercial Services, Government Solutions, and Parking Solutions. The Commercial Services segment provides automated toll and violations management, and title and registration services to rental car companies, fleet management companies, and other large fleet owners. The Government Solutions segment offers automated safety solutions to national, state, and local government agencies, including services and technologies that enable photo enforcement through road safety cameras to detect and process traffic violations for red-light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Parking Solutions segment provides an integrated suite of parking software and hardware solutions to universities, municipalities, parking operators, healthcare facilities, and transportation hubs. Verra Mobility Corporation was incorporated in 2016 and is headquartered in Mesa, Arizona.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial